Bryan M. Reasons Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Bryan M. Reasons.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Bryan M. Reasons. Bryan M. Reasons is a Chief Financial Officer in IMPAX LABORATORIES INC ($IPXL) and a Director in Aclaris Therapeutics, Inc. ($ACRS) and a EVP & CFO in Mallinckrodt plc ($MNK) and a Director in Recro Pharma, Inc. ($REPH) and a CFO in Amneal Pharmaceuticals, Inc. ($AMRX).

Address: C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD 94544 CA

Companies in which Bryan M. Reasons is an Insider

Aclaris Therapeutics, Inc.

Trading Symbol: ACRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: Director
Holdings: 16,209 shares
Current Value: $409,277
Latest Transaction: Jun 08 2020
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 16,209
Shares Sold: 0
Share Difference: +16,209
Value Difference: $0

Amneal Pharmaceuticals, Inc.

Trading Symbol: AMRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: CFO
Holdings: 82,986 shares
Latest Transaction: Aug 23 2018

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 2x
Shares Bought: 94,684
Shares Sold: 23,396
Share Difference: +71,288
Value Difference: +$553,315

Impax Laboratories, LLC

Trading Symbol: IPXL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2018
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 11x
Shares Bought: 23,272
Shares Sold: 95,422
Share Difference: -72,150
Value Difference: +$441,869

Mallinckrodt plc

Trading Symbol: MNK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: EVP & CFO
Holdings: 11,593 shares
Current Value: $587,533
Latest Transaction: Dec 07 2020
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 2x
Shares Bought: 17,979
Shares Sold: 6,386
Share Difference: +11,593
Value Difference: -$45,589

Recro Pharma, Inc.

Trading Symbol: REPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: Director
Holdings: 67,429 shares
Current Value: $542,803
Latest Transaction: Apr 22 2021
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 7x
Sell: 0x
Shares Bought: 76,278
Shares Sold: 0
Share Difference: +76,278
Value Difference: $0

Latest Insider Trading Transactions of Bryan M. Reasons

Sentiment: All, ACRS, AMRX, IPXL, MNK, REPH

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 22 2021REPHRecro Pharma, Inc.Reasons Bryan M.DirectorOption ExerciseA1.7138,01265,00138,012
Apr 22 2021REPHRecro Pharma, Inc.Reasons Bryan M.DirectorGrantA0.0026,923067,42940.5 K to 67.4 K (+66.47 %)
Dec 07 2020MNKMallinckrodt plcReasons Bryan M.EVP & CFOSellS0.175,40089111,59317 K to 11.6 K (-31.78 %)
Jun 08 2020ACRSAclaris Therapeuti ...Reasons Bryan M.DirectorOption ExerciseM0.007,33300
Jun 08 2020ACRSAclaris Therapeuti ...Reasons Bryan M.DirectorOption ExerciseA1.4116,50023,26516,500
Jun 08 2020ACRSAclaris Therapeuti ...Reasons Bryan M.DirectorBuyM0.007,333016,2098.9 K to 16.2 K (+82.62 %)
May 11 2020REPHRecro Pharma, Inc.Reasons Bryan M.DirectorOption ExerciseA8.3712,405103,83012,405

View all Bryan M. Reasons insider transactions.